Anti-HBsAg antibodies were detected at low levels that failed to reach significance in AdC6-gDHBV2–vaccinated mice; no antibodies were detected in mice that only received the AAV8-1.3HBV vector ( Supplemental Figure 1C ).
← all excerpts
A therapeutic HBV vaccine containing a checkpoint modifier enhances CD8+ T cell and antiviral responses.
1
—
—